Aurora Financial Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Aurora Financial Advisors’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$11K	Buy	+1,625	New	+$13.8K	0.01%	187

Other funds holding NAVB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Aurora Financial Advisors's NAVB Position: Q4 2017 in Review

Aurora Financial Advisors opened a new position in Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2017: 1,625 shares worth $11K. The stake represents 0.01% of the portfolio and ranks #187 among its holdings.

54 funds tracked by Wall St. Rank hold NAVB as of Q4 2017.

Aurora Financial Advisors held 1,625 shares of Navidea Biopharmaceuticals Inc. worth $11K as of Q4 2017.
Navidea Biopharmaceuticals Inc. was a new Aurora Financial Advisors position in Q4 2017.
Navidea Biopharmaceuticals Inc. made up 0.01% of Aurora Financial Advisors's portfolio in Q4 2017, its #187 holding.
54 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2017.

Based on Aurora Financial Advisors's 13F filing for Q4 2017, filed 16 Mar 2018.